ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 780

$1.22M Total Retail Price of All Prescriptions

Rank: 32 out of 780

758 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 758 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 758 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 17,574 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,501 866 S3 1 1
LEVOTHYROXINE SODIUM 838 675 2 5
OMEPRAZOLE 687 516 3 3
SIMVASTATIN 672 521 4 2
ZOLPIDEM TARTRATE 508 318 5 17
AMLODIPINE BESYLATE 477 401 6 4
POTASSIUM CHLORIDE 449 373 7 11
TORSEMIDE 426 372 8 114
TRAMADOL HCL 379 234 9 15
FUROSEMIDE 349 216 10 7
CITALOPRAM HBR 339 231 11 23
GABAPENTIN 312 182 12 13
METFORMIN HCL 299 236 13 8
LISINOPRIL 271 174 14 6
NABUMETONE 268 233 15 171
CLOPIDOGREL 265 250 16 34
CIPROFLOXACIN HCL 261 188 17 49
ATORVASTATIN CALCIUM 261 239 17 12
LOSARTAN POTASSIUM 257 197 19 18
DONEPEZIL HCL 256 256 20 31
PANTOPRAZOLE SODIUM 255 187 21 25
METOPROLOL TARTRATE 233 207 22 19
METOPROLOL SUCCINATE 223 181 23 20
NEXIUM 214 166 24 22
CYMBALTA 213 146 25 51
AZITHROMYCIN 202 152 26 38
DIOVAN 192 182 27 55
WARFARIN SODIUM 192 173 27 24
ALLOPURINOL 188 152 29 29
GLIMEPIRIDE 188 136 29 30
SINGULAIR 179 150 31 73
TAMSULOSIN HCL 177 151 32 36
PLAVIX 177 160 32 45
DIOVAN HCT 176 161 34 75
MELOXICAM 174 129 35 16
LYRICA 173 92 36 52
ATENOLOL 173 131 36 21
PREMARIN 163 137 R 38 110
AMLODIPINE BESYLATE-BENAZEPRIL 162 134 39 50
SPIRONOLACTONE 158 100 40 53
ISOSORBIDE MONONITRATE ER 153 119 41 60
CYCLOBENZAPRINE HCL 149 41 R 42 42
MECLIZINE HCL 148 123 43 83
SYNTHROID 146 134 44 77
CARISOPRODOL 139 32 R 45 67
SERTRALINE HCL 137 80 46 27
MONTELUKAST SODIUM 132 111 47 120
HYDROCHLOROTHIAZIDE 130 84 48 10
RAMIPRIL 130 116 48 70
BENAZEPRIL HCL 125 94 50 59
PROMETHAZINE HCL 124 51 R 51 66
VERAPAMIL ER 124 81 51 78
QUETIAPINE FUMARATE 123 115 53 81
ALENDRONATE SODIUM 120 98 54 44
NAMENDA 120 120 54 46
PRAVASTATIN SODIUM 118 80 56 9
CRESTOR 115 112 57 32
FENTANYL 112 45 S2 58 107
FLUTICASONE PROPIONATE 111 73 59 41
LEVOCETIRIZINE DIHYDROCHLORIDE 111 89 59 241
ESCITALOPRAM OXALATE 110 73 61 61
DIGOXIN 109 93 62 56
DICYCLOMINE HCL 107 73 63 213
GLYBURIDE-METFORMIN HCL 106 67 R 64 108
LEVOFLOXACIN 106 83 64 76
MIRTAZAPINE 106 103 64 58
CLOTRIMAZOLE-BETAMETHASONE 104 85 67 166
ENDOCET 102 60 S2 68 129
PRAMIPEXOLE DIHYDROCHLORIDE 102 86 68 156
LOSARTAN-HYDROCHLOROTHIAZIDE 100 82 70 33
OXYCODONE HCL-ACETAMINOPHEN 97 64 S2 71 146
CARVEDILOL 96 89 72 14
MEGESTROL ACETATE 96 91 R 72 161
ENALAPRIL MALEATE 96 88 72 64
PROPRANOLOL HCL 94 59 75 133
PROAIR HFA 93 40 76 62
AMOX TR-POTASSIUM CLAVULANATE 92 58 77 135
METHOCARBAMOL 91 63 R 78 84
MUPIROCIN 88 65 79 173
TRAZODONE HCL 84 73 80 35
BISOPROLOL-HYDROCHLOROTHIAZIDE 82 51 81 95
DILTIAZEM 24HR CD 81 65 82 138
KLOR-CON M20 78 69 83 57
AMIODARONE HCL 75 54 84 139
BISOPROLOL FUMARATE 74 46 85 143
MORPHINE SULFATE ER 73 0 S2 86 141
AMITRIPTYLINE HCL 73 45 R 86 48
FLUCONAZOLE 70 44 88 111
ZETIA 70 66 88 94
TRIAMTERENE-HCTZ 69 62 90 37
KLOR-CON 10 66 64 91 90
CEFDINIR 66 45 91 180
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 36 93 26
METHYLPREDNISOLONE 64 34 94 92
IBUPROFEN 63 53 95 93
PREDNISONE 63 60 95 40
JANUMET 62 59 97 208
VYTORIN 62 59 97 206
BUMETANIDE 61 53 99 96
PHENYTOIN SODIUM EXTENDED 59 41 100 128
DILTIAZEM 24HR ER 57 40 101 179
CLONIDINE HCL 57 37 101 28
TIZANIDINE HCL 57 23 101 82
CARBIDOPA-LEVODOPA 57 52 101 124
CEPHALEXIN 56 40 105 105
FOSINOPRIL SODIUM 56 16 105 112
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 37 105 88
DIPHENOXYLATE-ATROPINE 55 39 108 250
NAPROXEN 54 34 109 100
OXYBUTYNIN CHLORIDE 54 54 109 148
POLYETHYLENE GLYCOL 3350 53 45 111 79
RANITIDINE HCL 53 53 111 39
ACETAMINOPHEN-CODEINE 52 40 S3 113 116
PAROXETINE HCL 52 44 113 69
VENLAFAXINE HCL ER 51 15 115 117
BYSTOLIC 51 45 115 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.